Curriculum
The complete syllabus
281 lessons in 12 modules, taught in sequence but open in any order. Nine modules follow the practitioner curriculum; two more, drawn from the MultiOmix book, turn the toolkit into whole-patient practice.
Developed by Epivity Longevity Clinic in Norway in collaboration with the Norwegian health authorities, and offered in the United Arab Emirates by MultiOmix.
- Guided study
- 16 hours
- Deep dives
- 216
- Figures & tables
- 329
- Assessment items
- 250
Module 01 · Practitioner curriculum
Foundations of Longevity Medicine
This module establishes the conceptual and clinical foundation for the entire course. It defines what longevity medicine is (and is not), introduces the biology of aging and its clinical hallmarks, and builds the assessment and risk-stratification framework used throughout every subsequent module. Content is drawn from peer-reviewed literature and leading academic centers - Harvard Medical School, Harvard T.H. Chan School of Public Health, Stanford Center on Longevity, Stanford Medicine - together with prominent clinical and public voices in the field, including David Sinclair, PhD (Harvard Medical School), Peter Attia, MD, and consumer-facing longevity programs such as Bryan Johnson's Blueprint and Levels, which are examined critically as case studies rather than as clinical standards.
19
Lessons
1 h 14 min
Study time
View all 19 lessons and 5 knowledge checks
- 1.1What Is Longevity Medicine?◆5′
- 1.2Healthspan vs. Lifespan◆5′
- 1.3From Disease Treatment to Prevention2′
- 1.4The Biology of Aging◆5′
- 1.5The Hallmarks of Aging2′
- Knowledge check · 1.1-1.55 Q
- 1.6Risk Factors for Accelerated Aging2′
- 1.7The Longevity Patient2′
- 1.8The Longevity Assessment2′
- 1.9Biological Age vs. Chronological Age2′
- 1.10Preventive Risk Stratification2′
- Knowledge check · 1.6-1.103 Q
- 1.11The Major Pillars of Longevity2′
- 1.12Evidence-Based Longevity Medicine◆9′
- Knowledge check · 1.11-1.124 Q
- 1.13Personalization in Longevity Medicine2′
- 1.14From Data to Clinical Action2′
- 1.15The Physician's Role in Longevity2′
- 1.16Building a Longevity Care Plan2′
- 1.17Monitoring Progress Over Time2′
- 1.18The MultiOmix Approach2′
- Knowledge check · 1.13-1.183 Q
- 1.19Case workshop: the patient with nothing wrong3′
- Knowledge check · Case workshop4 Q
9 learning objectives · 10 key takeaways · 24 references
Open moduleModule 02 · Practitioner curriculum
Biomarkers & Comprehensive Health Assessment
Part 2 is the largest module in the course because it builds the single most-used clinical skill in longevity medicine: reading a comprehensive panel accurately. It covers what makes a biomarker clinically useful, how to read reference ranges critically, and a systematic walk-through of every major panel category - hematology, iron, renal, hepatic, lipid and advanced lipid, glycemic, inflammatory, thyroid, hormonal, micronutrient, homocysteine, and oxidative-stress markers - before moving into body composition, vascular, and functional assessment, and finally into the integration skills that turn 150+ data points into a small number of prioritized clinical actions. As in Part 1, sourcing is drawn from Harvard, Stanford, and peer-reviewed literature, together with the frameworks used by Peter Attia, David Sinclair, and consumer programs such as Bryan Johnson's Blueprint and Levels - again examined critically rather than adopted as clinical standard.
33
Lessons
1 h 31 min
Study time
View all 33 lessons and 5 knowledge checks
- 2.1The Role of Biomarkers in Longevity◆3′
- 2.2What Makes a Biomarker Clinically Useful?2′
- 2.3Reference Ranges vs. Optimal Ranges◆3′
- 2.4Reading a Comprehensive Blood Panel◆3′
- 2.5Complete Blood Count◆2′
- 2.6Iron Status◆2′
- Knowledge check · 2.2-2.63 Q
- 2.7Kidney Function◆2′
- 2.8Liver Function◆2′
- 2.9Lipid Profile◆2′
- 2.10ApoB & Advanced Lipid Assessment◆3′
- 2.11Glucose & Glycemic Health◆2′
- Knowledge check · 2.7-2.113 Q
- 2.12Insulin & Insulin Resistance◆2′
- 2.13Inflammation & Immune Health◆2′
- 2.14Thyroid Function◆2′
- 2.15Hormonal Health◆2′
- 2.16Vitamin & Micronutrient Status◆3′
- 2.17Homocysteine & Methylation◆2′
- 2.18Oxidative Stress & Cellular Health◆2′
- 2.19Cardiometabolic Risk Assessment◆2′
- 2.20Body Composition Assessment◆2′
- 2.21Blood Pressure & Vascular Health◆2′
- 2.22Fitness & Functional Assessment◆3′
- Knowledge check · 2.12-2.224 Q
- 2.23Sleep & Recovery Assessment◆2′
- 2.24Lifestyle & Behavioral Assessment◆2′
- 2.25Family & Medical History◆2′
- 2.26Integrating Multiple Data Sources2′
- 2.27Identifying Clinically Significant Patterns◆2′
- 2.28Prioritizing Patient Risks2′
- 2.29From Assessment to Action◆2′
- 2.30Longitudinal Biomarker Tracking◆2′
- 2.31Common Interpretation Errors2′
- 2.32Building the Comprehensive Health Profile◆2′
- Knowledge check · 2.25-2.325 Q
- 2.33Case workshop: four normal reports, one clear trend2′
- Knowledge check · Case workshop4 Q
8 learning objectives · 10 key takeaways · 24 references
Open moduleModule 03 · Practitioner curriculum
Cardiovascular Longevity
Cardiovascular disease is the leading cause of death worldwide, and it is also the domain of longevity medicine with the deepest and most rigorous evidence base of any pillar in this course. Part 3 builds a complete, evidence-graded approach to cardiovascular risk: the biology of the risk continuum, traditional and advanced risk markers (ApoB, Lp(a), coronary artery calcium), the major modifiable drivers (metabolic, inflammatory, behavioral), and the lifestyle and pharmacological interventions with genuine randomized-trial support behind them. Sourcing draws on landmark outcome trials (CTT, REDUCE-IT, FOURIER, CANTOS, LoDoCo2, PREDIMED), AHA/ACC/ESC guidelines, Harvard and Stanford research, and the frameworks used by Peter Attia and David Sinclair - with commercial programs such as Bryan Johnson's Blueprint and Levels again treated as case studies, not clinical standards.
29
Lessons
1 h 34 min
Study time
View all 29 lessons and 5 knowledge checks
- 3.1Cardiovascular Disease & Longevity◆4′
- 3.2The Cardiovascular Risk Continuum◆3′
- 3.3Traditional Cardiovascular Risk Factors◆2′
- 3.4Blood Pressure & Hypertension◆2′
- 3.5Atherosclerosis & Plaque Biology2′
- 3.6LDL Cholesterol & Cardiovascular Risk◆2′
- Knowledge check · 3.1-3.63 Q
- 3.7ApoB & Lipoprotein Particle Risk◆3′
- 3.8Lipoprotein(a)◆5′
- 3.9Triglycerides & Remnant Cholesterol◆3′
- 3.10HDL & Cardiovascular Health◆3′
- Knowledge check · 3.7-3.104 Q
- 3.11Inflammation & Cardiovascular Risk◆3′
- 3.12Endothelial Function2′
- 3.13Insulin Resistance & Cardiovascular Health◆3′
- 3.14Obesity & Cardiovascular Risk◆2′
- 3.15Diabetes & Cardiovascular Disease◆2′
- Knowledge check · 3.11-3.153 Q
- 3.16Coronary Artery Calcium◆4′
- 3.17Advanced Cardiovascular Risk Assessment◆2′
- 3.18Cardiovascular Genetics◆2′
- 3.19Cardiorespiratory Fitness◆2′
- 3.20Exercise & Cardiovascular Longevity2′
- 3.21Nutrition & Cardiovascular Health◆2′
- 3.22Sleep & Cardiovascular Health◆2′
- 3.23Stress & Autonomic Health2′
- 3.24Smoking, Alcohol & Environmental Risk◆2′
- 3.25Cardiovascular Prevention Strategies◆2′
- 3.26Pharmacological Risk Reduction2′
- 3.27Monitoring Cardiovascular Risk◆2′
- Knowledge check · 3.16-3.275 Q
- 3.28Building a Cardiovascular Longevity Plan◆6′
- 3.29Case workshop: a reassuring LDL that was not2′
- Knowledge check · Case workshop4 Q
8 learning objectives · 10 key takeaways · 34 references
Open moduleModule 04 · Practitioner curriculum
Metabolic Health & Insulin Resistance
Metabolic dysfunction - led by insulin resistance - is arguably the single most common upstream driver of chronic disease covered anywhere in this course: it accelerates cardiovascular risk (Part 3), drives fatty liver disease, and sits behind a large share of the hallmarks of aging introduced in Part 1. Part 4 builds a complete, mechanistic understanding of metabolic health, from glucose homeostasis and insulin resistance biology through the full progression from prediabetes to type 2 diabetes, and closes with the strongest available evidence on reversal - including two landmark trials, the Diabetes Prevention Program and DiRECT, that show metabolic dysfunction is often preventable and, in a meaningful subset of patients, reversible. As in prior modules, sourcing draws on Harvard, Stanford, landmark randomized trials, and the frameworks used by Peter Attia and David Sinclair, with commercial programs such as Bryan Johnson's Blueprint and Levels treated as case studies rather than clinical standards.
26
Lessons
1 h 18 min
Study time
View all 26 lessons and 5 knowledge checks
- 4.1Metabolic Health & Longevity◆2′
- 4.2Metabolic Syndrome◆3′
- 4.3Glucose Homeostasis◆2′
- 4.4Fasting Glucose◆2′
- 4.5HbA1c◆2′
- 4.6Fasting Insulin◆3′
- Knowledge check · 4.1-4.63 Q
- 4.7Insulin Resistance2′
- 4.8HOMA-IR◆2′
- 4.9Hyperinsulinemia◆2′
- 4.10Prediabetes◆3′
- 4.11Type 2 Diabetes2′
- Knowledge check · 4.114 Q
- 4.12Glucose Variability◆2′
- 4.13Continuous Glucose Monitoring2′
- 4.14Visceral Fat & Metabolic Risk◆2′
- 4.15Obesity & Metabolic Dysfunction2′
- 4.16Lipids & Metabolic Health◆2′
- 4.17Liver & Metabolic Health◆3′
- 4.18Nutrition & Metabolic Health◆2′
- 4.19Exercise & Insulin Sensitivity◆2′
- 4.20Sleep, Stress & Metabolism◆2′
- Knowledge check · 4.12-4.203 Q
- 4.21Metabolic Inflammation◆2′
- 4.22Metabolic Risk Assessment◆2′
- 4.23Reversing Metabolic Dysfunction◆4′
- 4.24Pharmacological Interventions◆2′
- 4.25Building a Metabolic Longevity Plan◆3′
- Knowledge check · 4.21-4.255 Q
- 4.26Case workshop: normal glucose, abnormal insulin2′
- Knowledge check · Case workshop4 Q
8 learning objectives · 10 key takeaways · 22 references
Open moduleModule 05 · Practitioner curriculum
Biological Age & Epigenetics
self-checks Part 5 goes beneath the biomarkers of Parts 2-4 to the molecular layer that helps explain why two patients of the same chronological age can have very different disease risk and physiological resilience - biological aging, measured through epigenetics. Building on the chronological-versus-biological-age distinction introduced in Part 1 (Section 1.9) and the one-carbon methylation biochemistry from Part 2 (Section 2.17), this module covers how DNA methylation changes across the lifespan, how epigenetic “clocks” translate that into an age estimate, what three successive generations of clocks were each built to predict, and - critically - what these tests can and cannot responsibly tell a physician today. As with Bryan Johnson's Blueprint and Levels in earlier parts, commercial epigenetic testing platforms such as TruDiagnostic are treated here as case studies in an emerging field, not as established clinical standards.
25
Lessons
1 h 22 min
Study time
View all 25 lessons and 5 knowledge checks
- 5.1Understanding Biological Aging◆3′
- 5.2Chronological Age vs. Biological Age◆3′
- 5.3Measuring Biological Age◆3′
- 5.4Epigenetics & Aging◆2′
- 5.5DNA Methylation2′
- 5.6Epigenetic Clocks◆2′
- Knowledge check · 5.1-5.63 Q
- 5.7First-Generation Epigenetic Clocks◆2′
- 5.8Second-Generation Epigenetic Clocks◆3′
- 5.9Third-Generation & Emerging Clocks◆4′
- Knowledge check · 5.95 Q
- 5.10Interpreting Biological Age Results◆2′
- 5.11Biological Age Acceleration◆4′
- 5.12Lifestyle & Epigenetic Aging◆2′
- 5.13Metabolic Health & Biological Aging◆2′
- 5.14Inflammation & Biological Aging◆2′
- 5.15Cardiovascular Aging◆2′
- 5.16Exercise & Biological Age◆2′
- 5.17Nutrition & Biological Age◆2′
- 5.18Sleep, Stress & Recovery◆2′
- 5.19Genetics vs. Epigenetics◆3′
- 5.20Clinical Applications of Epigenetic Testing◆2′
- Knowledge check · 5.10-5.203 Q
- 5.21Limitations of Biological Age Testing◆3′
- 5.22Tracking Biological Age Over Time◆2′
- 5.23From Biological Age to Clinical Action◆2′
- 5.24Building a Biological Aging Strategy◆5′
- Knowledge check · 5.22-5.244 Q
- 5.25Case workshop: a biological age result in clinic2′
- Knowledge check · Case workshop4 Q
8 learning objectives · 10 key takeaways · 24 references
Open moduleModule 06 · Practitioner curriculum
Genetics & Advanced Testing
self-checks Part 6 is the widest-lens module in the course. It starts with genetics proper - single variants, family history, and polygenic risk scores - moves through the specific genetic contributors to cardiovascular, metabolic, cancer, and drug-response risk, and then surveys the fast-growing field of advanced testing beyond genetics: telomeres, advanced lipid and metabolic panels, proteomics, metabolomics, and the microbiome. The throughline, consistent with every prior part, is disciplined evidence evaluation: some of this content (pharmacogenomics for specific drug-gene pairs, hereditary cancer syndromes) is genuinely practice-changing and underused; a meaningful share of what is marketed directly to consumers (unvalidated nutrigenomic panels, unproven microbiome-based dietary prescriptions) remains Tier 3-4 evidence dressed in Tier 1 language. Sourcing draws on CPIC, NCCN, ACMG, ESC, and ACC/AHA guidelines alongside the course's standing high-authority sources - Harvard, Stanford, Peter Attia, and David Sinclair - with commercial genetic and multi-omics platforms treated, as in prior parts, as case studies rather than clinical standards.
27
Lessons
1 h 18 min
Study time
View all 27 lessons and 5 knowledge checks
- 6.1Introduction to Genetics in Longevity◆3′
- 6.2Genetics vs. Genomics◆2′
- 6.3Genetic Risk & Disease Susceptibility◆2′
- 6.4Family History & Genetic Risk◆2′
- 6.5Single Nucleotide Variants◆2′
- 6.6Polygenic Risk Scores◆2′
- Knowledge check · 6.2-6.64 Q
- 6.7Cardiovascular Genetics◆3′
- 6.8Metabolic & Diabetes Genetics◆2′
- 6.9Cancer Genetics◆2′
- 6.10Pharmacogenomics◆3′
- 6.11Nutrigenomics◆2′
- Knowledge check · 6.7-6.113 Q
- 6.12Mitochondrial Genetics◆2′
- 6.13Telomeres & Cellular Aging◆2′
- 6.14Advanced Lipid Testing◆2′
- 6.15Advanced Metabolic Testing◆2′
- 6.16Advanced Inflammatory Testing◆2′
- 6.17Hormonal & Endocrine Testing◆2′
- 6.18Microbiome Testing◆2′
- Knowledge check · 6.13-6.184 Q
- 6.19Proteomics◆2′
- 6.20Metabolomics◆2′
- 6.21Multi-Omics Medicine◆2′
- 6.22Choosing the Right Advanced Test◆2′
- 6.23Interpreting Genetic & Advanced Reports◆2′
- 6.24Clinical Relevance vs. Incidental Findings◆2′
- 6.25Limitations & Ethical Considerations◆2′
- 6.26From Advanced Testing to Clinical Action◆4′
- Knowledge check · 6.19-6.264 Q
- 6.27Case workshop: one diagnosis, a whole family2′
- Knowledge check · Case workshop4 Q
8 learning objectives · 10 key takeaways · 22 references
Open moduleModule 07 · Practitioner curriculum
Exercise, Fitness & Physical Performance
self-checks Exercise is, by a wide margin, the single most-studied and most effective intervention covered anywhere in this course - and Part 7 is where its evidence base gets the depth it deserves. Cardiorespiratory fitness (Part 3, Section 3.19), muscular strength, and exercise's downstream effects on metabolic (Part 4, Section 4.19), cardiovascular (Part 3, Section 3.20), and biological-aging (Part 5, Section 5.16) outcomes have each been introduced already; this module builds the complete physiological and practical picture, from VO2max testing and heart rate variability through resistance training, zone-based and high-intensity prescription, recovery science, and how to translate all of it into a sustainable, individualized longevity exercise plan. As throughout this course, wearable fitness technology is treated with the same evidence discipline applied to Bryan Johnson's Blueprint and Levels in earlier parts - a genuinely useful but imperfect tool, not an infallible oracle.
27
Lessons
1 h 25 min
Study time
View all 27 lessons and 6 knowledge checks
- 7.1Exercise & Longevity◆5′
- 7.2Physical Activity vs. Exercise2′
- 7.3Cardiorespiratory Fitness2′
- 7.4VO₂max◆4′
- 7.5Exercise Testing◆2′
- 7.6Resting Heart Rate & Heart Rate Response◆3′
- Knowledge check · 7.1-7.63 Q
- 7.7Heart Rate Variability2′
- 7.8Strength & Muscular Fitness◆2′
- 7.9Muscle Mass & Sarcopenia◆4′
- 7.10Functional Fitness◆2′
- 7.11Resistance Training◆3′
- 7.12Aerobic Training◆2′
- 7.13High-Intensity Training◆2′
- 7.14Zone-Based Training◆2′
- Knowledge check · 7.9-7.143 Q
- 7.15Exercise Prescription◆2′
- 7.16Exercise & Metabolic Health◆2′
- 7.17Exercise & Cardiovascular Health◆2′
- 7.18Exercise & Brain Health◆2′
- Knowledge check · 7.183 Q
- 7.19Exercise & Biological Aging◆2′
- 7.20Recovery & Adaptation◆2′
- 7.21Overtraining & Exercise Risk◆2′
- 7.22Sleep & Exercise◆2′
- 7.23Nutrition & Performance◆3′
- 7.24Wearables & Fitness Data◆2′
- Knowledge check · 7.20-7.243 Q
- 7.25Building a Longevity Exercise Plan◆2′
- 7.26Monitoring Physical Performance◆4′
- Knowledge check · 7.25-7.263 Q
- 7.27Case workshop: prescribing exercise like a drug2′
- Knowledge check · Case workshop4 Q
8 learning objectives · 10 key takeaways · 19 references
Open moduleModule 08 · Practitioner curriculum
Nutrition, Sleep & Recovery
evidence · self-checks Nutrition, sleep, and recovery are the three daily-repeated inputs that shape almost every biomarker and outcome covered elsewhere in this course - cardiovascular risk (Part 3), metabolic health (Part 4), biological aging (Part 5), and physical performance (Part 7) all sit downstream of what a patient eats, how well they sleep, and whether their body gets a genuine chance to recover. Earlier parts introduced nutrition and sleep as risk-modifying factors within a specific organ system; this module is where they get the depth of treatment they deserve as clinical disciplines in their own right - macronutrient physiology, dietary-pattern evidence, fasting and meal timing, alcohol's revised risk profile, sleep architecture and disorders, circadian biology, the physiology of stress and recovery, and how to translate all of it into a single, individualized, sustainable plan. As throughout this course, commercial supplement and wellness-tracking claims are held to the same evidence bar as Bryan Johnson's Blueprint and Levels protocols discussed in earlier parts - useful signal exists, but it must be separated carefully from marketing.
27
Lessons
1 h 30 min
Study time
View all 27 lessons and 5 knowledge checks
- 8.1Nutrition & Longevity◆4′
- 8.2Energy Balance & Metabolic Health◆3′
- 8.3Macronutrients◆2′
- 8.4Protein & Muscle Health◆3′
- 8.5Carbohydrates & Metabolic Health◆2′
- 8.6Dietary Fats◆2′
- 8.7Fiber & Gut Health◆2′
- Knowledge check · 8.4-8.73 Q
- 8.8Micronutrients◆2′
- 8.9Dietary Patterns◆3′
- 8.10Meal Timing & Circadian Biology◆2′
- 8.11Caloric Restriction & Longevity◆2′
- 8.12Intermittent Fasting◆3′
- 8.13Alcohol & Longevity◆3′
- 8.14Sleep & Longevity◆3′
- 8.15Sleep Architecture◆2′
- Knowledge check · 8.13-8.153 Q
- 8.16Sleep Assessment◆2′
- 8.17Circadian Rhythm◆2′
- 8.18Sleep Disorders◆5′
- 8.19Stress & Recovery◆2′
- 8.20Autonomic Balance◆2′
- 8.21Recovery & Adaptation◆3′
- 8.22Mental Health & Longevity◆2′
- Knowledge check · 8.18-8.223 Q
- 8.23Lifestyle Environment◆2′
- 8.24Nutritional Supplementation◆3′
- Knowledge check · 8.23-8.246 Q
- 8.25Personalized Nutrition◆3′
- 8.26Building a Nutrition & Recovery Plan◆5′
- 8.27Case workshop: what the wearable was telling her2′
- Knowledge check · Case workshop4 Q
8 learning objectives · 10 key takeaways · 26 references
Open moduleModule 09 · Practitioner curriculum
Longevity Interventions & Protocols
evidence · self-checks Parts 1 through 8 built the complete diagnostic and physiological foundation of longevity medicine - biomarkers, cardiovascular and metabolic risk, biological aging, genetics, exercise physiology, and nutrition and sleep science. Part 9 is where all of that assessment work becomes action. This module covers how to translate findings into a structured, individualized, evidence-graded protocol: the foundational role of lifestyle and behavior change, how to layer targeted clinical interventions (hormonal optimization, evidence-based supplementation) and pharmacological options on top of that foundation, how to evaluate emerging and experimental therapies without overstating their evidence, and how to build the ongoing cycle of monitoring and adjustment that separates a real longevity practice from a one-time consultation. As throughout this course, every intervention category here - including hormone therapy, peptides, and IV protocols, all heavily marketed in the commercial longevity space that Bryan Johnson's Blueprint and Levels represent - is held to the same evidence-tiering discipline established in Part 1, Section 1.12, with clear distinctions drawn between established clinical practice and genuinely experimental care.
27
Lessons
1 h 30 min
Study time
View all 27 lessons and 5 knowledge checks
- 9.1Principles of Longevity Interventions◆3′
- 9.2Lifestyle as the Foundation◆3′
- 9.3Personalized Longevity Protocols◆2′
- 9.4Behavior Change & Adherence◆3′
- 9.5Weight Management◆3′
- 9.6Metabolic Optimization◆2′
- 9.7Cardiovascular Risk Reduction◆2′
- 9.8Exercise Prescription2′
- 9.9Nutrition Protocols2′
- 9.10Sleep Optimization2′
- 9.11Stress & Recovery Protocols2′
- 9.12Supplementation2′
- 9.13Hormonal Optimization◆6′
- 9.14Peptide Therapies◆3′
- 9.15Pharmacological Longevity Interventions◆4′
- Knowledge check · 9.2-9.155 Q
- 9.16Emerging Longevity Therapies◆2′
- 9.17IV & Infusion Therapies◆2′
- 9.18Preventive Screening◆2′
- 9.19Risk-Benefit Assessment◆2′
- Knowledge check · 9.15-9.193 Q
- 9.20Monitoring Treatment Response◆2′
- 9.21Protocol Adjustment◆2′
- 9.22Patient-Specific Prioritization◆2′
- 9.23Clinical Safety & Contraindications◆3′
- 9.24Evidence-Based vs. Experimental Care◆4′
- Knowledge check · 9.22-9.243 Q
- 9.25Building the MultiOmix Longevity Protocol◆4′
- 9.26Longitudinal Longevity Management◆3′
- Knowledge check · 9.25-9.264 Q
- 9.27Case workshop: starting a GLP-1 agonist the right way2′
- Knowledge check · Case workshop4 Q
8 learning objectives · 10 key takeaways · 21 references
Open moduleModule 10 · Practitioner curriculum
Functional Medicine: Principles and Clinical Practice
This module trains a practising physician to deliver functional medicine competently and credibly: to find why a patient became unwell, map the interacting causes, choose tests with discipline, and build a personalised, evidence-graded plan that integrates with conventional care. Ten lessons, each with a knowledge check, a four-case library with model answers, and a twenty-question module assessment.
14
Lessons
1 h 47 min
Study time
View all 14 lessons and 11 knowledge checks
- 10.1What functional medicine is5′
- Knowledge check · Lesson 10.13 Q
- 10.2Systems biology and the Functional Medicine Matrix4′
- Knowledge check · Lesson 10.23 Q
- 10.3The functional consultation5′
- Knowledge check · Lesson 10.33 Q
- 10.4Functional laboratory medicine6′
- Knowledge check · Lesson 10.43 Q
- 10.5Core imbalances I: metabolism, mitochondria, inflammation and immunity5′
- Knowledge check · Lesson 10.53 Q
- 10.6Core imbalances II: gut, biotransformation and hormones5′
- Knowledge check · Lesson 10.63 Q
- 10.7Lifestyle as the therapeutic foundation5′
- Knowledge check · Lesson 10.73 Q
- 10.8Targeted therapeutics: nutraceuticals, pharmacology and the therapeutic order6′
- Knowledge check · Lesson 10.83 Q
- 10.9Building the personalised plan and driving behaviour change4′
- Knowledge check · Lesson 10.93 Q
- 10.10Monitoring, outcomes, ethics and running a functional practice4′
- Knowledge check · Lesson 10.103 Q
- 10.11Case 1 · The executive who is always tired2′
- 10.12Case 2 · Perimenopause and healthy aging2′
- 10.13Case 3 · Bloating, fatigue and a thyroid diagnosis2′
- 10.14Case 4 · Multimorbidity seeking healthspan2′
- Knowledge check · Module assessment20 Q
9 learning objectives · 10 key takeaways · 18 references
Open moduleModule 11 · From the MultiOmix book
Longevity Across the Lifespan & Integrated Case Studies
Parts 1-9 built the toolkit one system at a time. This module puts it to work on whole patients. The first half walks decade by decade through what a longevity plan should prioritise - from the baseline that only the twenties can provide to the functional independence that becomes the real outcome after seventy. The second half is a case conference: four patients followed across the course return with their complete protocols, showing depth, a single reorganising finding, sequencing, and restraint as four different shapes of the same seven-step process.
13
Lessons
39 min
Study time
View all 13 lessons and 2 knowledge checks
- 11.1Why a Longevity Plan Must Be Decade-Specific2′
- 11.2Twenties to Early Thirties: Building the Baseline2′
- 11.3Mid-Thirties to Mid-Forties: The First Real Signals2′
- 11.4Late Forties to Fifties: When Risk Becomes Visible2′
- 11.5The Sixties: Protecting Function, Not Just Numbers2′
- 11.6Seventies and Beyond: Independence as the Outcome2′
- 11.7The Decade-at-a-Glance Framework3′
- Knowledge check · Life-stage planning6 Q
- 11.8Case Conference: Four Patients, Four Protocols2′
- 11.9Case 1 · Fatima - The Full Arc2′
- 11.10Case 2 · Sofia - The Finding That Reorganizes Everything2′
- 11.11Case 3 · Kristian - The Discipline of Sequencing2′
- 11.12Case 4 · Viktor - Knowing What to Say No To2′
- 11.13Four Protocols, One Process2′
- Knowledge check · Integrated case studies6 Q
7 learning objectives · 9 key takeaways
Open moduleModule 12 · From the MultiOmix book
Critical Appraisal, the Longevity Industry & the Next Decade
Patients arrive with protocols they have already paid for and headlines they have already read. This final module equips the physician to answer both. It builds a working evidence hierarchy, a ten-point red-flag checklist and a six-question method for reading any study, then applies them to the claims most often met in practice - consumer biological-age kits, exosome and stem-cell infusions, NAD+ subscriptions, unregulated peptides and wearable 'longevity scores'. It closes with an honest account of the research pipeline as of 2026 - partial reprogramming, senolytics, the TAME trial and AI-accelerated discovery - and a ninety-day plan for turning the course into practice.
14
Lessons
52 min
Study time
View all 14 lessons and 3 knowledge checks
- 12.1Anders and the Claim Built to Survive Scrutiny3′
- 12.2The Evidence Hierarchy2′
- 12.3Ten Red Flags You Can Check in Fifteen Minutes3′
- 12.4Reading a Study Like a Clinician2′
- 12.5Public Self-Experimentation Is Not a Clinical Trial2′
- 12.6Common Industry Claims, Evaluated Honestly2′
- 12.7The Pre-Purchase Checklist - and Where Anders Landed3′
- Knowledge check · Critical appraisal8 Q
- 12.8What 'The Next Decade' Actually Means2′
- 12.9Partial Reprogramming: From Mice to a First Human Trial2′
- 12.10Senolytics: The Correction After the Hype2′
- 12.11The Metformin Question and the TAME Trial2′
- 12.12Where AI Is Actually Changing Things2′
- 12.13What to Bet On - and What Not To3′
- Knowledge check · The research frontier6 Q
- 12.14Closing Lecture: The First 90 Days5′
- Knowledge check · The first ninety days3 Q
8 learning objectives · 11 key takeaways
Open moduleAssessment & certification
How completion is assessed
Formative checks
250 single-best-answer questions placed through the modules, each with an explained rationale. Retake freely; your best score is kept.
Final assessment
50 questions sampled in proportion from all twelve modules, with a 60-minute guide time. The pass mark is 80%.
Live workshop
After the digital modules, a one-day live workshop where you apply the course to real patient cases with the faculty.
Certificate
Issued after you have completed both the digital modules and the workshop, carrying your name, the date and the curriculum covered.